High risk of cardiovascular diseases after diagnosis of multiple sclerosis

Elham Jadidi1, Mohammad Mohammadi, Tahereh Moradi

  • 1Institute of Environmental Medicine, Division of Epidemiology, Karolinska Institutet, Stockholm, Sweden.

Multiple Sclerosis (Houndmills, Basingstoke, England)
|February 1, 2013
PubMed

Insights

Multiple sclerosis (MS) patients face higher risks for myocardial infarction, stroke, and heart failure, especially women. Cardiovascular disease (CVD) prevention is crucial for this population.

Area of Science:

  • Neurology
  • Cardiology
  • Epidemiology

Background:

  • Multiple sclerosis (MS) is a chronic neurological condition.
  • Understanding cardiovascular disease (CVD) risks in MS patients is vital for prognosis and outcomes.
  • Existing research may not fully capture CVD risk heterogeneity in MS.

Purpose of the Study:

  • To assess the risk of myocardial infarction (MI), stroke, heart failure (HF), and atrial fibrillation (AF) or flutter in MS patients.
  • To investigate these risks across different ethnicities, sexes, and age groups.
  • To identify specific demographic groups within the MS population that may be at higher risk.

Main Methods:

  • Nationwide population-based cohort study in Sweden.
  • Inclusion of 8,281 MS patients hospitalized between 1987-2009 and 76,640 matched controls.
  • Poisson regression analysis with stratification by sex, age, and country of birth.

Main Results:

  • MS patients showed significantly higher incidence rate ratios for MI (1.85), stroke (1.71), and HF (1.97) compared to controls.
  • A decreased risk was observed for AF/Flutter (0.63) in MS patients.
  • Increased CVD risks were particularly pronounced in women with MS.

Conclusions:

  • MS patients, especially women, require vigilant cardiovascular surveillance and preventive measures.
  • The findings highlight a significant association between MS and increased risk for several major cardiovascular events.
  • Targeted CVD prevention strategies are recommended for the MS population.
Abstract

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...